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angio ‑MSCT an 87‑ year ‑old woman with symp‑
tomatic aortic valve stenosis (mean aortic gra‑
dient, 62 mm Hg; aortic valve area, 0.5 cm2), 
normal left ventricular size and function, and 
the EuroSCORE II of 9.4% (baseline estimated 
glomerular filtration rate of 45.4 ml/min/1.73 m2, 
diabetes mellitus, and hypertension). The Evo‑
lut R 29 mm (Medtronic, Minneapolis, Minne‑
sota, United States) was deployed after predi‑
lation (20 mm × 4 cm Edwards Transfemoral 
Balloon Catheter, Edwards Lifesciences, Irvine, 
California, United States) (Supplementary ma‑
terial, Figure S1). Angiography showed aortic re‑
gurgitation and inflow outer diameter that mea‑
sured 89.7% of the maximal annulus diameter 
(25.3 mm and 27.7 mm, respectively) and 87.2% 
of the nominal inflow diameter (25.3 mm and 
29 mm, respectively). The waist of the THV was 
overexpanded (25.9 mm versus 23 mm nominal 
size). Postdilation (25 mm × 4 cm, Edwards Life‑
sciences) led to an increase in inflow expansion 
(100.7% of the maximal annulus diameter and 
96.2% of the nominal inflow diameter) and de‑
creased regurgitation.
A detailed analysis of the baseline aortic root 
by IVUS corresponded closely with MSCT, both 
showing an oval shape annulus with similar di‑
mensions and no calcifications (Figure 1, cross sec‑
tions 1 and 2). Both visualized severe calcifica‑
tions at the base of all 3 cusps (Figure 1, cross sec‑
tions 3 and 4) and no calcifications within com‑
missural end points (Figure 1, cross sections 6 and 7). 
The noncoronary cusp free margin was immobile 
Introduction The geometry and expansion of 
transcatheter heart valve (THV) have an impact 
on paravalvular leak and subsequent leaflet dete‑
rioration, particularly after valve ‑in ‑valve proce‑
dures.1,2 Planning of transcatheter aortic valve re‑
placement (TAVR) relies on multislice computed 
tomography (MSCT) along with fluoroscopy and 
transesophageal echocardiography. Also, a 3‑di‑
mensional reconstruction has been applied to ro‑
tational angiography to create MSCT ‑like imag‑
es.3 The Visions PV.035 intravascular ultrasound 
(IVUS) catheter (Philips North America, Andover, 
Massachusetts, United States) with a 60‑mm im‑
aging field, is capable of tracking over 0.035‑ to 
0.038‑in guidewires used during TAVR. We used 
the Visions PV.035 catheter for the online assess‑
ment of the aortic root and THV geometry to pro‑
vide a tomographic perspective and the highest vi‑
sual resolution during TAVR for native aortic ste‑
nosis or a failed bioprosthetic aortic surgical valve.
Methods In a small case series, we enrolled 
patients qualified by the  Heart Team upon 
angio ‑MSCT (SOMATOM, Siemens Health‑
ineers, Erlangen, Germany) for transfemoral 
TAVR. The Visions PV.035 IVUS catheters were 
used for online guidance of the procedure.
The study was approved by the local ethics 
committee. Informed consent to participate in 
the study was obtained from all patients.
Results and discussion  Patient no. 1  The Heart 
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 Figure 1 Corresponding computed tomography and intravascular ultrasound (IVUS) images of the aortic root anatomy, obtained sequentially at baseline, 
immediately post Evolut R 29 mm implantation, and after postdilation (patient no. 1). Unless marked otherwise, multislice computed tomography (MSCT) images 
were obtained in systole. Baseline MSCT and IVUS images correspond to: aortic annulus (cross sections 1 and 2), cusps base (cross section 3), aorta narrowest 
lumen cross section (cross section 4), cusps free margins (cross section 5), the level of sinuses with maximum aorta dimension (cross sections 6 and 7), and plane 
45 mm above the annulus (cross sections 8 and 9). Procedural IVUS images correspond to: THV inflow (annulus level and cusps base), constrained segment (nadir of 
leaflets and center of coaptation), and outflow. Post ‑procedure MSCT images at levels corresponding to the procedural IVUS images. MSCT annulus measurements 
were 2.16 cm × 2.82 cm, 8.1 cm (perimeter) and 4.84 cm2 (area). The aorta measurements at the level of the cusps were 2.94 × 3.11 × 3.31 cm (sinus -to -commissure 
diameters) and 7.7 cm2; at its narrowest lumen, 3.2 × 3.33 × 3.64 cm and 9.14 cm2; at the level of sinuses, 3.24 × 3.32 × 3.53 cm and 9.25 cm2; and at 45 mm above 
the annulus, 3.25 × 3.32 cm and 8.49 cm2 (respectively). Corresponding baseline IVUS were as follows: at the annulus 19.3 × 27.7 mm, 75.8 mm and 417.1 mm2; 
at the level of cusps 29.6 × 30.6 × 31.7 mm and 736.2 mm2; at its narrowest lumen cross -sectional area 31.7 × 31.8 × 32.6 mm and 910.8 mm2; at the level of 
the sinuses 33.6 × 33.7 × 35.4 mm and 912.8 mm2; and 45 mm height above the annulus plane 32.6 × 33.3 mm and 822.8 mm2. Final THV inner inflow cross ‑sectional 
area was 78.3% of the baseline annulus area (with its maximal diameter ratio being 92% of the maximal baseline annulus diameter). The corresponding THV inflow 
area expansion was 49% of that predicted with the manufacturer’s chart (with its maximal diameter ratio being 88% of that predicated). Final inner -THV frame 
cross ‑sectional areas measured at the nadir of leaflets and at the level of center of coaptation were 91% of that predicted from manufacturer’s chart for both. 
The increase in the aortic root dimension during the TAVR procedure were 195 mm2 as assessed at the cusps base, 113 mm2 as assessed at the site of narrowest 
lumen, 135 mm2 as assessed at the level of sinuses, and 140 mm2 as assessed 45 mm above the annulus plane.
 Abbreviations: IVS, interventricular septum; LA, left atrium; LCA, left coronary artery; LCC, left coronary cusp; LV, left ventricle; NCC, noncoronary cusp; RA, right 
atrium; RAA, right atrial appendage; RCA, right coronary artery; RCC, right coronary cusp
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the tops of stent posts (Supplementary materi‑
al, Figure S3, cross section 4). Both showed simi‑
lar spatial configuration of the echolucent cusps 
(free of calcifications or thrombus and mobile). 
Valve orifice dimensions on IVUS defined by 
the inner area in systole between the cusps in 
their open position were 14.6 mm × 16 mm and 
179.1 mm2 area (Supplementary material, Figure 
S3, cross section 3). The IVUS transducer was lo‑
cated closer to the right coronary take ‑off en‑
abling good visualization, whereas the left cor‑
onary take ‑off appeared to be located too far 
away (Supplementary material, Figure S3, cross 
sections 4 and 5).
IVUS performed post ‑Evolut R implanta‑
tion showed circular valve frame inflow close‑
ly adjacent to the inner surface of the biopros‑
thesis ring (Supplementary material, Figure S3, 
cross section 3). The other cross sections were 
also circular (particularly the nadir of leaflets 
and the center of coaptation). The inner cross‑
‑sectional area of the THV inflow was smaller 
than the inner ring area of the surgical valve 
(Supplementary material, Figure S3, cross sec‑
tions 3). IVUS indicated that whereas the THV 
constrained segment was underexpanded at the 
level of the nadir of leaflets (Supplementary ma‑
terial, Figure S3, cross section 4), it was overex‑
panded at the level of the center of coaptation 
(Supplementary material, Figure S3, cross sec‑
tion 5) with an outflow dimension smaller than 
predicated (Supplementary material, Figure S3, 
cross section 6). Acute lumen gain was associat‑
ed with cusp compression, but not an increase in 
bioprosthesis ring dimensions, with simultane‑
ous increase in inner distances between the bio‑
prosthesis stent posts measured at their upper 
points (Supplementary material, Figure S3, cross 
section 4). Overall aortic root dimensions (in‑
cluding its annulus) did not change (Supplemen‑
tary material, Figure S3).
Both patients Reports of the feasibility of IVUS 
for TAVR did not include the analysis of THV ge‑
ometry and valve ‑in ‑valve procedures.4,5 Cur‑
rently, we documented: 1) concordance between 
quantitative and qualitative results of MSCT 
as compared with IVUS of a native aortic root 
and a failed bioprosthesis; 2) good agreement 
in terms of THV frame volumetric assessment; 
3) mechanisms of acute lumen gain relying on 
cusp compression along with THV frame adapta‑
tion to the anatomy of the aortic root (particular‑
ly the geometry of cusp calcifications) with sub‑
stantial increase in the aortic root dimensions 
or an increase in the inner distances between 
the bioprosthesis stent posts during the valve‑
‑in ‑valve procedure; and 4) the value of the on‑
line IVUS for insights into postdilation effects.
Severe calcifications are powerful reflectors of 
ultrasound affecting detailed real ‑life IVUS eval‑
uation of patients qualified for TAVR (patient 
although not calcified and was clearly visible on 
IVUS (Figure 1, cross sections 5 and 6). Free mar‑
gins of the left and the right coronary cusps were 
calcified and poorly seen on IVUS due to shad‑
owing (Figure 1, cross sections 5 and 6). Whereas 
the right coronary take ‑off was easily seen with 
IVUS, the left coronary take ‑off appeared to be 
located too far away from the transducer (located 
near the commissural end point between the right 
coronary cusp and noncoronary cusp).
IVUS was done immediately post ‑Evolut R de‑
ployment and then after postdilation. Both runs 
showed an oval ‑shaped THV frame inflow (Figure 1, 
cross sections 1 and 2), similarly to other cross 
sections, particularly nadir of leaflets and cen‑
ter of coaptation (Figure 1, cross sections 3 and 7), 
whereas the outflow was circular (Figure 1, cross 
sections 8 and 9). Evolut R measured after post‑
dilation showed that the inflow and outflow re‑
mained underexpanded as compared with base‑
line annulus dimensions and dimensions pre‑
dicted from the manufacturer’s chart. The ex‑
pansion of the THV constrained segment was 
also smaller than nominal; however, correspond‑
ing maximal diameters (measured at the nadir 
of leaflets and center of coaptation) were larg‑
er than predicted (26% and 14% overexpansion, 
respectively). The mechanism of acute lumen 
gain post ‑TAVR was cusp compression (mainly 
the noncoronary cusp) and concomitant increase 
in aortic root dimensions while postdilation lead 
to more cusp compression, but not additional in‑
crease in the aortic root dimension. IVUS visu‑
alized normal THV leaflet motion (Figure 1).
Patient no. 2 A 91‑year ‑old man with severe re‑
nal impairment (baseline estimated glomeru‑
lar filtration rate of 33 ml/min/1.73 m2), coro‑
nary artery disease, atherosclerosis obliterans, 
dyslipidemia, diabetes mellitus, and hyperten‑
sion (EuroSCORE II, 39%) presented with symp‑
tomatic significant insufficiency of the Hancock 
II 23 mm bioprosthesis (Medtronic) inserted 
14 years earlier for aortic stenosis. Echocardio‑
gram demonstrated the left ventricle with a di‑
astolic diameter of 54 mm, septal wall thick‑
ness of 14 mm, and ejection fraction of 50%. 
He was treated with transfemoral TAVR using 
Evolut R 23 mm. Angiography showed no aor‑
tic regurgitation. THV inflow outer diameter 
measured 83.3% of the maximal inner ‑ring di‑
ameter (17.5 mm and 21 mm, respectively) and 
76.1% of nominal size (17.5 mm and 23 mm, re‑
spectively). The waist of the valve was underex‑
panded (18.6 mm versus 20 mm nominal size) 
(Supplementary material, Figure S2).
A detailed analysis of the baseline aortic root 
by IVUS corresponded closely with preproce‑
dural MSCT (Supplementary material, Figure 
S3), documenting a circular bioprosthesis sew‑
ing ring with severe calcifications and simi‑
lar dimensions and similar distances between 
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required to keep the transducer perpendicular 
to the aortic root or  THV long axis for the most 
accurate measurements.
The IVUS offered online tomographic perspec‑
tive with the highest visual resolution, allowing 
the gradual insight into the actually achieved 
THV dimensions and the mechanisms of thera‑
py. Future large prospective studies should con‑
firm our hypotheses and assess clinical utility of 
IVUS for TAVR guidance particularly in the set‑
ting of a heavily calcified landing zone, including 
balloon expandable valves and those deployed 
with controlled mechanical expansion as well as 
TAVR ‑in ‑TAVR procedures (perhaps using cath‑
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no. 1). IVUS visualized the annulus when there 
were no calcifications, calcium deposits were lo‑
calized far from the transducer, deep at the base 
of the cusps, or were not continuous, allowing 
parts of the beam to penetrate. Conversely, there 
was substantial shadowing associated with re‑
verberations and multiple reflections from cal‑
cium deposits at the free margins of the cusps 
located close to the transducer. In patient no. 2, 
calcium deposits occupied the valve stent (its 
ring and posts), but not the valve leaflets. De‑
spite that, precise evaluation of the change in 
the inner ‑ring dimension and its relation to cor‑
responding baseline annulus dimensions advo‑
cate IVUS use for the guidance of bioprosthetic 
valve fracture. Also, IVUS appears to be useful 
for both the BASILICA (bioprosthetic or native 
aortic scallop intentional laceration to prevent 
coronary artery obstruction) and the BI ‑SILICA 
(bicuspid scallop intentional laceration to induce 
circularization of the aortic implant) guidance.
Decision to postdilate (patient no. 1) was 
made because of substantial aortic insufficien‑
cy and space measured on angiography for more 
expansion of THV inflow (Supplementary ma‑
terial, Figure S1). Although IVUS could not doc‑
ument paravalvular flow directly, we visualized 
the site of suboptimal prosthesis expansion (an‑
nulus and constrained segment) with incom‑
plete THV frame apposition. THV underexpan‑
sion at the upper inflow and the constrained seg‑
ment (both at the nadir of leaflets and the center 
of coaptation) corresponded to baseline severe 
calcifications within the cusps’ base. Maximal 
inner ‑diameters within the constrained segment 
were actually bigger than predicted in both pa‑
tients. This is consistent with our previous vol‑
umetric quantitative MSCT analysis of supra‑
‑annular THVs6 showing that minimum out‑
er diameter of the waist of THV was similar to 
the predicted diameter, but that other waist di‑
mensions (ie, maximal diameter and area) were 
bigger. The above could be a consequence of in‑
flow underexpansion which promotes waist de‑
formation. THV dimensions increased with post‑
dilation sized to baseline inner ‑annulus dimen‑
sions; however, they did not reach the nominal 
and were smaller than baseline inner ‑annulus 
dimensions.
MSCT for THV frame or bioprosthesis evalua‑
tion is affected by image artifacts. Angiographic 
measurements are made on a 2‑dimensional sin‑
gle projection of the 3‑dimensional valve frame 
and require calibration. The above, along with 
the inconsistent C arm and table settings, result 
in imprecise measurements of THV absolute di‑
mensions. IVUS could be the preferred tool for 
the assessment of THV structural integrity and 
dimensions, especially among patients with re‑
nal impairment. IVUS cannot visualize coro‑
nary take ‑off if it is located far from the ostia; 
and when performing IVUS during TAVR, it is 
